Edition:
United States

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

2.87USD
21 Sep 2018
Change (% chg)

$-0.33 (-10.31%)
Prev Close
$3.20
Open
$3.20
Day's High
$3.29
Day's Low
$2.87
Volume
18,504
Avg. Vol
24,259
52-wk High
$15.34
52-wk Low
$1.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.644
Mar '18 0.00 -0.515
FY 2017 Dec '17 0.00 -0.466
Sep '17 0.00 -0.425
Jun '17 0.00 -0.336
Mar '17 0.00 -0.311
FY 2016 Dec '16 0.00 -0.303
Sep '16 0.00 -0.288
Jun '16 0.00 -0.377
Mar '16 0.00 -0.268
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 4 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 4 -0.56 -0.49 -0.65 -0.41
Quarter Ending Dec-18 3 -0.60 -0.53 -0.66 -0.44
Year Ending Dec-18 3 -2.34 -2.18 -2.47 -1.87
Year Ending Dec-19 4 -2.38 -1.63 -3.07 -2.75
LT Growth Rate (%) 1 1.20 1.20 1.20 1.30
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.33 32.69
P/E High - Last 5 Yrs. -- 278.75 47.23
P/E Low - Last 5 Yrs. -- 97.93 24.79
Beta -- 0.61 0.87
Price to Sales (TTM) -- 110.30 6.46
Price to Book (MRQ) 1.29 12.48 3.90
Price to Tangible Book (MRQ) 1.29 18.90 5.96
Price to Cash Flow (TTM) -- 62.41 23.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 175.09 8.38
Sales (TTM) vs TTM 1 Yr. Ago -- 92.96 6.69
Sales - 5 Yr. Growth Rate -- 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -91.68 283.36 25.56
EPS (TTM) vs TTM 1 Yr. Ago -65.55 -- --
EPS - 5 Yr. Growth Rate -- 23.65 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.57 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.19
Current Ratio (MRQ) 3.83 5.49 2.97
LT Debt to Equity (MRQ) 0.00 15.10 11.24
Total Debt to Equity (MRQ) 10.18 18.62 14.06
Interest Coverage (TTM) -- -215.83 35.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.67
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -177.00 15.88
Operating Margin (TTM) -- -607.80 3.65
Operating Margin - 5 Yr. Avg. -- -190.63 11.00
Pre-Tax Margin (TTM) -- -604.88 3.97
Pre-Tax Margin - 5 Yr. Avg. -- -193.42 11.19
Net Profit Margin (TTM) -- -599.69 0.70
Net Profit Margin - 5 Yr. Avg. -- -191.17 7.52
Effective Tax Rate (TTM) -- 11.60 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.16 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,335,375 714,979,821
Net Income/Employee (TTM) -- -5,831,664 82,568,832
Receivable Turnover (TTM) -- 4.20 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) 0.00 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -104.72 0.80 9.75
Return on Assets - 5 Yr. Avg. -- 2.53 10.91
Return on Investment (TTM) -142.13 1.50 12.72
Return on Investment - 5 Yr. Avg. -- 2.04 14.03
Return on Equity (TTM) -- 0.19 14.85
Return on Equity - 5 Yr. Avg. -- -2.23 15.38
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -24.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aileron Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.85%
# of Holders: 30
Total Shares Held: 2,187,831
3 Mo. Net Change: -135,997
# New Positions: 9
# Closed Positions: 27
# Increased Positions: 13
# Reduced Positions: 36
# Net Buyers: -23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.